Inc. (Nasdaq: PEGY) (“Pineapple” or the “Company”), a leading provider of sustainable solar energy and backup power to households, businesses, municipalities, and for servicing existing systems, today ...

Subject to the terms of the Contingent Value Rights Agreement dated March 25, 2022 and amended on March 27, 2024, which governs the rights of Pineapple and the CVR Holders, each CVR represents the ...

Pineapple Energy (PEGY) will distribute to the holders of its non-transferable Contingent Value Rights a payment of $850,269, or $0.35 per CVR.

Lumos Pharma, Inc. faces a significant risk concerning the potential valueless expiration of the Contingent Value Rights (CVRs) offered to stockholders post-2024 Merger and Offer completion.

unsecured Contingent Value Right per share payable on achievement of certain milestones. If you are a Lumos shareholder, click here to learn more about your rights and options . Altair Engineering Inc ...

Click here for an analysis of Cartesian Therapeutics' recent stock rebound and RNA cell therapy assets, including mixed ...